Unfortunately, most people don't think of bioavailability and efficacy. I know for pain relief, if I take it on an empty stomach with 12 ounces of water, it passes the stomach quickly and pain relief is faster.
Stomach benefit aside, people may be thinking even if enteric doesn't get absorbed as well, then just take a double dose and it is still cheaper than Vazalore. That is higher risk that I wouldn't do, but in this bad inflation environment, it could be getting factored in. Think about it, many of the potential users of Vazalore are probably on fixed income. More of their income is being used to heat/cool and feed themselves, so something has to give. I haven't been able to find a chart showing heart health populations stratified by retirement income/assets, but that has to come into play.